Infectious Diseases
Latest News
FDA approves cantharidin for molluscum contagiosum
The development marks the first FDA-approved treatment for the condition.
Practice Alert
Screening for hepatitis B: Where the CDC and USPSTF diverge
The CDC recently issued guidance on screening for hepatitis B infection. Here’s a look at how (and why) these recommendations differ from those of...
Latest News
Case report describes pediatric RIME triggered by norovirus
The study author says the incidence of RIME appears to be increasing, although its true epidemiology is unknown.
Conference Coverage
Infection-related chronic illness: A new paradigm for research and treatment
Researchers are looking to build a common research agenda for infection-related chronic illnesses to “understand the epidemiology and pathogenesis...
Conference Coverage
Research points toward combination therapy for Lyme and improved diagnostics
Lyme disease researchers are investigating combination therapy to address “persister” bacteria and diagnostic tests that test directly for the...
News from the FDA/CDC
Pneumococcal vaccine label adds injection-site risk
Reports of injection-site necrosis emerged after the vaccine had been approved by the FDA and was administered to a large, diverse, real-world...
News from the FDA/CDC
FDA approves RSV monoclonal antibody for all infants
The long-acting antibody is given as a single intramuscular injection.
Feature
Long COVID and vaccines: Separating facts from falsehoods
Discussions of vaccination with patients, including those with long COVID, are often fraught and challenging. “There’s a lot of fear that they...
Latest News
LAMA-LABA surpasses corticosteroid combination as COPD therapy
Large matched cohort study suggests stronger safety and effectiveness outcomes with LAMA-LABA inhalers vs. ICS-LABA inhalers.
Latest News
A decade after first DAA, only one in three are HCV free
Patients face barriers to being cured at every step of the way, from being diagnosed to accessing breakthrough DAA agents.
News
Nearly one in five in U.S. still hadn’t gotten COVID by end of 2022
The CDC analyzed donor blood from 143,000 people every 3 months during 2022.